Author:
Srigadha Vivek K.,Prabhash Kumar,Noronha Vanita,Joshi Amit,Patil Vijay M.,Menon Nandini,Singh Ajay K.,Shah Minit
Subject
Cancer Research,Oncology (nursing),Drug Guides,Ophthalmology
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cabozantinib plus nivolumab and ipilimumab in renal cell carcinoma;Cancer Research, Statistics, and Treatment;2023
2. Authors’ reply to Bhattacharya;Cancer Research, Statistics, and Treatment;2023
3. An epistolary account of cabozantinib’s significance in the combat against renal cell, hepatocellular, and thyroid carcinoma from the perspective of a cancer combatant;Cancer Research, Statistics, and Treatment;2023
4. Identification of EGFR mutations in type II papillary renal cell carcinoma;Cancer Research, Statistics, and Treatment;2023